1. Introduction {#sec1-foods-09-00705}
===============

Ethnopharmacological literature compiled by our ancestors has indicated the potential of plants in the treatment of several health complications affecting mankind. The therapeutic properties of plants have been ascribed to biologically active chemical compounds called secondary metabolites. Alkaloids, terpenoids, and phenolic compounds are the different classes of secondary metabolites, which naturally occur in plants and have been found to exhibit biological effects, such as anti-inflammatory, anti-cancer, anti-diabetic, and antioxidant properties, amongst others \[[@B1-foods-09-00705],[@B2-foods-09-00705],[@B3-foods-09-00705],[@B4-foods-09-00705]\]. Besides, some of these bioactive compounds (such as polyphenols) possess an important role as dietary constituents, characterized by several health-promoting properties. In the last years, the quest for novel lead candidates for the management of human ailments continues to fuel the study of bioactive compounds from both plants and plant-foods for human nutrition. In particular, several studies have been conducted to test the antioxidant and pharmacological activities of different plant extracts (such as hydroalcoholic, water or ethyl acetate extracts) \[[@B5-foods-09-00705],[@B6-foods-09-00705],[@B7-foods-09-00705]\].

In this direction, the genus Fibigia, belonging to the Brassicaceae family, is distributed in Egypt, Southern Europe, Caucasus, and the Middle East. Brassicaceae, formerly known as Cruciferae because of their 4-petalled flowers, are a very useful edible group of plants. They encompass many edible plants like broccoli, mustard greens, cauliflower, cabbage, kale, collards, turnips, Chinese Bok Choy, and so on. Many important oil-producing plants are in this family. They also tend to have a pungent taste, as in the mustard greens and seeds, and cress. Besides, one cup of a decoction prepared from the leaves and stem of *F. eriocarpa* (DC.) Boiss. is used against the common cold \[[@B8-foods-09-00705]\]. However, to date, few information exists regarding the use of *F. clypeata* as food ingredient; in fact, to the best of our knowledge, the edible part of this plant (also known as paper pumpkinseed) is the young leaf. In particular, the raw leaves are eaten in the eastern Mediterranean as part of salads. No additional information is provided in the scientific literature regarding other uses as a food ingredient. Overall, a decoction prepared from the stem and fruits of *F. clypeata* (L.) Medik. is used against kidney stones \[[@B9-foods-09-00705]\], whilst powdered fruits of *F. macrocarpa* Boiss. are used against cattle infertility \[[@B10-foods-09-00705]\]. *F. clypeata* extracts were previously reported exhibiting anti-leishmanial activities on the intracellular amastigote form of the parasite and induced nitrous oxide production by human macrophages \[[@B11-foods-09-00705]\]. Therefore, according to the literature, the comprehensive chemical characterization, together with the description of other biological properties (such as enzyme inhibitory and/or anti-cancer potential) of the Fibigia species, is still scarce.

Considering the importance of plant bioactive compounds as related to health-promoting attributes, several recent works analyzed the novel source of phytochemicals by using high-resolution targeted/untargeted mass spectrometry approaches \[[@B4-foods-09-00705],[@B6-foods-09-00705],[@B7-foods-09-00705]\]. In fact, according to the literature \[[@B12-foods-09-00705]\], using liquid chromatography coupled with mass spectrometry (LC-MS) is recommended to profile and then quantify antioxidant compounds (such as polyphenols) in both plant and food matrices. Therefore, the main goal of this work was to assess the potential enzyme inhibitory activity, in vitro antioxidant properties, and cytotoxicity of the ethyl acetate, methanol, and aqueous extract of *F. clypeata*. Moreover, LC-MS was used to elucidate the detailed phytochemical profile of the different extracts. It is expected that the data generated from this study will provide for the first time valuable and comprehensive scientific information on the poorly studied Fibigia species, serving as the baseline information for future detailed investigations.

2. Material and Methods {#sec2-foods-09-00705}
=======================

2.1. Plant Material and Preparation of Extracts {#sec2dot1-foods-09-00705}
-----------------------------------------------

The plant material of *F. clypeata* was collected in the area of Hanönü village (Kastamonu, Turkey) in the summer of 2019. Taxonomic identification was performed by the botanist Dr. Ismail Senkardes (Marmara University, Department of Pharmaceutical Botany, Istanbul, Turkey), and 1 voucher specimen was deposited at the herbarium of Selcuk University (MARE-19856). The grinding of naturally dried aerial parts of the plant was carried out by a laboratory mill.

For the extraction step, the maceration technique based on two different organic solvents, namely ethyl acetate (EA) and methanol. For this purpose, samples of the plant material (5 g) were macerated with 100 mL of each solvent for 24 h at room temperature (about 25 °C). Then, the solvents were evaporated under vacuum using a rotary evaporator. The aqueous extract was prepared by traditional infusion technique, and plant material (5 g) was kept with the boiled water (100 mL) for 20 min. Then the water extract was filtered and then lyophilized. All extracts were stored at +4 °C until analysis.

2.2. Profiling of Bioactive Compounds in the Different Extracts {#sec2dot2-foods-09-00705}
---------------------------------------------------------------

To determine total phenolic and flavonoid contents of *F. clypeata* extracts, colorimetric methods were used based on our previous work \[[@B13-foods-09-00705]\]. In this regard, the results were finally expressed as namely gallic acid equivalents (GAE) for total phenolics and rutin equivalents (RE) for total flavonoids.

Thereafter, the phytochemical analysis of each plant extract was carried out using Agilent 1200 Infinity HPLC and Agilent 6530B QTOF spectrometer (Agilent Technologies, Santa Clara, CA, USA). The conditions of the analyses were described previously \[[@B14-foods-09-00705]\]. The identification was based on the obtained fragmentation patterns, which were compared to the data available in the scientific literature and the Metlin database (<https://metlin.scripps.edu>).

2.3. Determination of Antioxidant and Enzyme Inhibitory Effects {#sec2dot3-foods-09-00705}
---------------------------------------------------------------

To detect antioxidant properties, several chemical assays were used, including different mechanisms, namely, radical scavenging, reducing power, and metal chelating. Trolox (TE) and ethylenediaminetetraacetic acid (EDTA) were used as standard antioxidant compounds. Obtained results were expressed as equivalents of these compounds, Grochowski, et al. \[[@B15-foods-09-00705]\]. To detect inhibitory effects on enzymes, colorimetric enzyme inhibition assays were used, and these assays included tyrosinase, α-glucosidase, α-amylase, and cholinesterases. Some standard inhibitors (galantamine, kojic acid, and acarbose) were used as positive controls.

2.4. Cell Assays {#sec2dot4-foods-09-00705}
----------------

### 2.4.1. Cell Lines and Reagents {#sec2dot4dot1-foods-09-00705}

In vitro assays were carried out using normal VERO (ECACC, No. 84113001) and cancer FaDu (ATCC, HTB-43) and SCC-25 (ATCC, CRL-1628) cell lines. Cell media used in experiments, antibiotic supplement (Penicillin-Streptomycin Solution), and PBS (phosphate buffer saline) were provided by Corning (Tewksbury, MA, USA), and Foetal Bovine Serum (FBS) by Biowest (Nuaillé, France). The DMF (dimethylformamide) was acquired from Avantor Performance Materials Poland S.A (Gliwice, Poland). The DMSO (dimethyl sulfoxide), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), and hydrocortisone were purchased from Sigma-Aldrich (St. Louis, MO, USA) and SDS (sodium dodecyl sulfate) from AppliChem (AppliChem GmbH, Darmstadt, Germany).

### 2.4.2. Cell Cultures {#sec2dot4dot2-foods-09-00705}

The VERO cells were maintained using DMEM (Dulbecco's Modified Eagle Medium), FaDu cells using Modified Eagle Medium (MEM), whereas SCC-25 required Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM-F12) supplemented with hydrocortisone. Cell propagation was performed using 10% FBS in appropriate cell media (growth media), whereas the experiments were carried out using media supplemented with 2% FBS. All cell lines were cultivated in media supplemented with Penicillin-Streptomycin Solution and the propagation of cells was carried out at 37 °C in 5% CO~2~ atmosphere (CO~2~ incubator, Panasonic Healthcare Co., Ltd., Tokyo, Japan).

### 2.4.3. Evaluation of Cytotoxic Properties {#sec2dot4dot3-foods-09-00705}

The viability of tested cells was assessed using a modified MTT (microculture tetrazolium) test, which measures the ability of succinate dehydrogenase to reduce MTT salt into formazan. Formazan crystals are insoluble in water and are dissolved using a mixture of SDS (14%), DMF (36%), and PBS (50%), producing a purple color. Usually, after overnight incubation, the absorbance was measured at 2 wavelengths---540 and 620 nm. The succinate dehydrogenase activity was correlated with the metabolic activity of the cells allowing to assess the viability of the cells \[[@B16-foods-09-00705]\]. The stock solutions were obtained by dissolving the samples in DMSO (50 mg/mL) and sterilized using syringe filters (0.2 µm). Trypsinized VERO, FaDu, or SCC-25 cells were suspended in appropriate growth media in the density of 1.5 × 10^5^ cells/mL, 2 × 10^5^ cells/mL or 3 × 10^5^ cells/mL, respectively, and cultured in 96-well plates (Corning). After overnight pre-incubation required for obtaining a semi-confluent cell monolayer, the cells were treated for 72 h with tested extracts in culture media containing 2% FBS in concentrations varying from 1.95 to 1000 µg/mL. Control cells were grown in medium containing 2% of FBS. The cytotoxicity of DMSO used as a sample solvent was also evaluated. After the incubation, all the media was removed. The plates were rinsed with sterile PBS and 100 µL per well of 10% of MTT solution (5 mg/mL) in appropriate media was added. After 4 h of incubation, 100 µL per well of solvent containing sodium dodecyl sulfate (14%), dimethylformamide (36%), and phosphate buffer saline (50%) was added. The next day, the absorbance was measured with the use of an Epoch reader (BioTek Instruments, Inc., Winooski, VT, USA) running Gen5 program (2.01.14; BioTek) and data were exported to the GraphPad Prism (v8.0.1) for further analysis. The viability of cells treated with tested samples was compared with control cells, and the values of CC~50~ (concentration resulting in 50% inhibition) and CC~10~ (concentration resulting in 10% inhibition) were estimated based on dose-response curves.

2.5. Statistical Analysis {#sec2dot5-foods-09-00705}
-------------------------

The analysis of the variance (one-way ANOVA) followed by Duncan's Multiple Range post hoc test (*p* \< 0.05) was done using the data from in vitro spectrophotometric and enzymatic assays. In particular, the software PASW Statistics 26.0 (SPSS Inc., Chicago, IL, USA) was used. Therefore, means without a common superscript letter showed significant differences (*p* \< 0.05). Pearson's correlations (*p* \< 0.05; two-tailed) were then calculated using PASW Statistics 26.0. Regarding the cell assays, the tests were carried out in triplicate and rerun at least thrice. For statistical evaluation, a 2-way ANOVA followed by Tukey's multiple comparison test was used.

3. Results and Discussion {#sec3-foods-09-00705}
=========================

3.1. Phytochemical Profile Determination {#sec3dot1-foods-09-00705}
----------------------------------------

In this work, standard in vitro spectrophotometric analyses was used to determine the total phenolic and flavonoid contents of the ethyl acetate, methanolic, and aqueous extracts of *F. clypeata*. The results are presented in [Table 1](#foods-09-00705-t001){ref-type="table"}.

As can be observed from the table, the highest phenolic (33.42 mg GAE/g) and flavonoid (21.58 mg RE/g) contents were obtained when considering the methanolic extract. Besides, a strong correlation coefficient (*p* \< 0.01) of 0.809 was found between the two different assays ([Supplementary Material Table S1](#app1-foods-09-00705){ref-type="app"}). In our previous study on *F. eriocarpa* \[[@B16-foods-09-00705]\], the highest total phenolic level was determined in ethyl acetate extract (41.87 mg GAE/g), followed methanol (35.42 mg GAE/g) and water (33.63 mg GAE/g). Similar to current results, methanol extract (24 mg RE/g) of *F. eriocarpa* contained the highest level of flavonoids. In accordance with our results, several researchers reported that methanol was one of the best solvents to extract flavonoids \[[@B17-foods-09-00705],[@B18-foods-09-00705],[@B19-foods-09-00705]\]. However, spectrophotometric analyses are mainly able to provide an insight into the content of the bioactive compound of herbal extracts without providing detailed phytochemical composition. Besides, a possible interference of non-phenolic compounds characterizing the extracts has been reported yielding false-positive results \[[@B12-foods-09-00705]\]. Therefore, in the present study, high performance liquid chromatography coupled to mass spectrometry was used to assess the detailed profile of *F. clypeata* extracts. The identification of compounds was performed by HPLC-ESI-QTOF mass spectrometry in negative ionization mode. The tentatively identified compounds from the extracts were summarized in [Table 2](#foods-09-00705-t002){ref-type="table"}, and chromatograms were reported in [Figure 1](#foods-09-00705-f001){ref-type="fig"}.

Overall, in our experimental conditions, **51** compounds were tentatively identified, mainly consisting of polyphenols and phenolic derivatives, such as flavonoids and phenolic acids. Interestingly, we also found two glucosinolates (i.e., compounds **4** and **5**), namely *p*-Methoxy-2-hydroxy-2-phenylethyl glucosinolate and *p*-Methoxy-2-hydroxy-2-phenylethyl glucosinolate---desulfo, previously described in crucifer seeds \[[@B22-foods-09-00705]\]. In addition, **1**, **43**, and **57**, corresponding to a caffeic acid-*O*-hexoside derivative, a caffeyl alcohol *O*-glucopyranoside, and a ferulic acid derivative, respectively. These latter were tentatively identified in all the extracts tested. In addition, compounds **6** and **7**, **8** and **9**, exhibited the same fragmentation patterns and were characterized from the water extract as dihydroxybenzoic acid hexosides and *p*-coumaric acid ethyl ester derivatives. The fragmentation of compound **16** corresponded to *p*-coumaric acid hexoside, which was tentatively identified from the ethyl acetate extract. Compound **31**, with \[M-H\]- at *m*/*z* 193, was identified as ferulic acid. Moreover, several sesquiterpenes (i.e., compounds **44**, **46**, and **51**) were also tentatively characterized ([Table 2](#foods-09-00705-t002){ref-type="table"}).

3.2. Enzyme Inhibition Activity {#sec3dot2-foods-09-00705}
-------------------------------

Enzyme inhibitors hold a significant share in clinically approved drugs, and their attractiveness has been associated with their specific roles in several metabolic pathways. Drug discovery and development focus on identifying and optimizing lead compounds that act on specific enzymes \[[@B26-foods-09-00705]\]. In the present study, the ability of *F. clypeata* extracts to inhibit key enzymes targeted in the management of Alzheimer's disease, skin hyperpigmentation, and type II diabetes was assessed. About 50 million people worldwide have dementia and Alzheimer's disease, the most common form of dementia accounts for 60--70% of the cases \[[@B27-foods-09-00705]\]. Based on the cholinergic hypothesis, the lack of neurotransmitters hinders connections between neurons and thus affects the brain's neuronal circuits \[[@B28-foods-09-00705]\]. The inhibition of acetylcholinesterase has been advocated in the management of mild cognitive impairment due to Alzheimer's disease. Clinically approved drugs, such as donepezil, galantamine, and rivastigmine, containing acetylcholinesterase inhibitor as an active ingredient, are currently used in the management of Alzheimer's disease \[[@B29-foods-09-00705]\]. Later, the function of another cholinesterase enzyme, namely, butyrylcholinesterase, has also been evoked. The increased activity of butyrylcholinesterase, up to 120%, in the late stage of Alzheimer's disease has been related to the wasting away of the brain and aggravation of behavioral and cognitive dysfunction in Alzheimer's disease patients \[[@B30-foods-09-00705]\]. Besides, it has been reported that butyrylcholinesterase could compensate a lack of acetylcholinesterase in the acetylcholinesterase knockout mice model \[[@B31-foods-09-00705]\]. These facts have brought the role and need for butyrylcholinesterase inhibition into the limelight. Finding a novel candidate showing both acetylcholinesterase and butyrylcholinesterase inhibitory activity represents an interesting therapeutic strategy for the management of Alzheimer's disease. However, as reported in the literature, further ad-hoc studies are strongly required to find also possible markers of the neurodegenerative disease \[[@B32-foods-09-00705]\]. As can be observed from [Table 3](#foods-09-00705-t003){ref-type="table"}, the ethyl acetate and methanol extracts of *F. clypeata* showed inhibitory action against both cholinesterase enzymes.

The methanolic extract (4.87 mg GALAE/g) was most active against acetylcholinesterase. Both the ethyl acetate (3.54 mg GALAE/g) and methanol (3.52 mg GALAE/g) extracts showed comparable inhibition against butyrylcholinesterase. In our previous study, the best cholinesterase inhibition abilities of *F. eriocarpa* were reported for ethyl acetate (2.12 mg GALAE/g for AChE and 2.01 mg GAELAE/g for BChE) and methanol (1.83 mg GALAE/g for AChE and 1.08 mg GALAE/g for BChE) extracts \[[@B16-foods-09-00705]\]. Based on these values, the ethyl acetate and methanol extracts of *F. clypeata* were stronger than *F. eriocarpa*. In the literature survey, several researchers reported the significant cholinesterase inhibitory abilities for other solvents (ethyl acetate, chloroform, and methanol, etc.) rather than water \[[@B33-foods-09-00705],[@B34-foods-09-00705],[@B35-foods-09-00705]\]. This fact could be explained to extract low polarity compounds such as alkaloids and terpenoids with these solvents, and they could be more active on cholinesterases.

Likewise, the methanolic and ethyl acetate extracts of *F. clypeata* showed potent inhibition against tyrosinase. The inhibition of tyrosinase is crucial in the management of skin hyperpigmentation conditions, such as melasma and freckles. Inhibiting tyrosinase is directly related to the reduced production of the dark brown melanin. Moreover, the increased public interest towards naturally derived products, including cosmetic and dermatological products, has fueled the need for natural tyrosinase inhibitors. Another species of the *Fibigia* genus, namely *F. eriocarpa*, was previously reported to inhibit tyrosinase \[[@B16-foods-09-00705]\]. In contrast to our present findings, the ethyl acetate and methanol extracts of *F. eriocarpa* were not active on tyrosinase. This fact could be explained with the differences of chemical profiles in these extracts and the complex interactions of phytochemicals. However, methanolic extracts exhibited stronger actions on tyrosinase in earlier studies conducted by some researchers \[[@B36-foods-09-00705],[@B37-foods-09-00705]\].

Monitoring hyperglycemia, the hallmark of type II diabetes, is playing a pivotal role in the management of the disease. Apart from dietary modifications, the inhibition of carbohydrate hydrolyzing enzymes assists in maintaining a normal glycemic level. The inhibition of α-amylase, which is situated in the upper gastrointestinal tract and catalyzes the initial breakdown of ingested polysaccharides into oligosaccharides and the inhibition of α-glucosidase, which is situated in the brush border of the small intestine and catalyzes the last step of carbohydrate digestion, significantly prevents glycemic peaks. However, prominent α-amylase inhibition has been associated with gastrointestinal discomforts caused by the fermentation of undigested carbohydrates in the colon. In the present study, a low α-amylase inhibition was observed while the ethyl acetate (22.32 mmol ACAE/g) and methanol (24.68 mmol ACAE/g) extracts of *F. clypeata* exhibited potent α-glucosidase inhibitory action. It was noted that, in general, the water extract of *F. clypeata* exhibited the lowest enzymatic inhibition. The higher activity of the ethyl acetate and methanol extracts might be related to the synergistic action of the different bioactive compounds present in these extracts. Anti-diabetic properties of the ethyl acetate and methanol extracts of *F. clypeata* were stronger than those of *F. eriocarpa* (amylase: 0.44 mmol ACAE/g for ethyl acetate and 0.43 mmol ACAE/g for methanol; glucosidase: 5.01 mmol ACAE/g for ethyl acetate and 1.57 mmol ACAE/g for methanol) in our previous paper. Additionally, it is worth mentioning the level of the different bioactive compounds might have also affected enzyme activity. The alkaloidal amine, sinapine, tentatively characterized from the ethyl acetate extract of *F. clypeata* was previously reported to inhibit acetylcholinesterase isolated from rat cerebral homogenate with an IC50 of 3.66 µmol/L \[[@B38-foods-09-00705]\]. Regarding correlations between total phenolic-flavonoid content with enzymatic assays, we found strong correlation coefficients when considering only TFC (total flavonoid content) values. In this regard, total flavonoids were strongly correlated to AChE (0.870; *p* \< 0.01), tyrosinase (0.795; *p* \< 0.05), α-glucosidase (0.771; *p* \< 0.05), and BChE (0.705; *p* \< 0.05) inhibition values ([Table S1](#app1-foods-09-00705){ref-type="app"}).

3.3. In Vitro Antioxidant Activity of the Tested Extracts {#sec3dot3-foods-09-00705}
---------------------------------------------------------

The role of oxidative stress in the onset and/or progression of human ailments supports the systematic antioxidant evaluation of studied plant extracts. Antioxidants can act by different mechanisms, namely, hydrogen atom transfer, single electron transfer, or transition metal chelation \[[@B39-foods-09-00705]\]. In this study, multiple antioxidant assays were used to obtain a comprehensive understanding of the antioxidant properties of the *F. clypeata* extracts. As presented in [Table 4](#foods-09-00705-t004){ref-type="table"}, the methanolic extract (96.52 and 109.10 mg TE/g, for DPPH and ABTS, respectively) of *F. clypeata* showed potent radical scavenging properties.

Likewise, the methanolic extract exhibited the highest reducing potent in the CUPRAC (154.02 mg TE/g) and FRAP (104.85 mg TE/g) assays. Obtained results could be compared with earlier studies on other *Fibigia* or Brassicaceae species. For example, the antioxidant properties in *F. eriocarpa* extracts can be ranked methanol \> ethyl acetate \> water. However, the antioxidant abilities of the water extract of *F. clypeata* were stronger than that of *F. eriocarpa*. \[[@B16-foods-09-00705]\] Besides, different levels for antioxidant properties in some Brassicaceae species have been reported in the literature \[[@B40-foods-09-00705],[@B41-foods-09-00705],[@B42-foods-09-00705]\]. At this point, the chemical profiles of the extracts were closely related to their antioxidant properties. In this sense, several compounds present in *F. clypeata* methanolic extract might be responsible for the observed activity. Sinapic acid was reported to exhibit radical scavenging potential \[[@B43-foods-09-00705]\]. Caffeic acid has been reported to be an effective radical scavenger and reducing agent as well as a metal chelator \[[@B44-foods-09-00705]\]. In terms of metal chelating, the aqueous extract of *F. clypeata* showed the highest activity. These findings suggest that bioactive compounds present in the methanolic extract exhibited mostly radical scavenging and reducing potential, while compounds present in the aqueous extract were potential metal chelators. Regarding the potential correlation between TPC and TFC values, we found strong correlation coefficients between TPC and some antioxidant assays, such as DPPH (0.943; *p* \< 0.01), CUPRAC (0.954; *p* \< 0.01), FRAP (0.874; *p* \< 0.01), and ABTS (0.790; *p* \< 0.05) values. In addition, total flavonoids were inversely correlated to chelating activity (−0.902; *p* \< 0.01) and strongly correlated to DPPH values (0.876; *p* \< 0.01) ([Table S1](#app1-foods-09-00705){ref-type="app"}).

3.4. Cell Assays {#sec3dot4-foods-09-00705}
----------------

To assess the anti-cancer potential of *Fibigia clypeata* extracts, their cytotoxicity was measured on two cancer cell lines belonging to the group of head and neck squamous cell carcinomas (HNSCC), i.e., squamous cell carcinoma of the pharynx (FaDu) and squamous cell carcinoma of the tongue (SCC-25) and compared with the results obtained for the normal VERO cell line. The results of cytotoxicity evaluation are presented in [Table 5](#foods-09-00705-t005){ref-type="table"}.

In the case of VERO cells, no cytotoxicity was observed for methanolic and aqueous extracts. The ethyl acetate extract showed a cytotoxic effect in concentrations above 125 µg/mL, but it was impossible to calculate the CC50 value because even in the highest tested concentration of 1000 µg/mL the viability of VERO cells was above 50% ([Figure 2](#foods-09-00705-f002){ref-type="fig"}).

Similarly, it was impossible to calculate CC50 for aqueous extract on FaDu cells. Both ethyl acetate and methanolic extracts showed selective toxicity towards FaDu cells. In the case of SCC-25 cell line, selective toxicity was observed for all tested extracts. The CC50 and CC10 values of ethyl acetate extract on both cancer cell lines showed a statistically important difference (*p* \< 0.001). In the case of methanolic extract tested on FaDu and SCC-25, the CC50 values were similar, but a significant difference was found for the CC10 values (*p* \< 0.001) ([Figure 3](#foods-09-00705-f003){ref-type="fig"} and [Figure 4](#foods-09-00705-f004){ref-type="fig"}).

The criteria of classification of plant extract cytotoxicity according to the protocols suggested by the National Cancer Institute (NCI) \[[@B45-foods-09-00705]\] and selected literature are shown in [Table 6](#foods-09-00705-t006){ref-type="table"} \[[@B45-foods-09-00705],[@B46-foods-09-00705],[@B47-foods-09-00705],[@B48-foods-09-00705]\].

According to this criterion, all tested extracts can be classified as non-cytotoxic towards the VERO cell line. In the case of cancer cell lines, ethyl acetate and methanolic extracts tested on FaDu and methanolic and aqueous extracts tested on SCC-25 can be classified as weakly cytotoxic. However, the selective activity towards cancer cell lines encourages further investigations focused on the isolation of bioactive constituents and testing their anti-cancer potential. Di Giorgio et al. \[[@B11-foods-09-00705]\] studied the immunomodulatory and anti-leishmanial activities of Lebanese plants and reported the cytotoxicity of *F. clypeata* extracts assessed on the THP1 human monocyte cell line by colorimetric determination of cell viability using the oxidation--reduction indicator Alamar Blue. The aqueous and dichloromethane extracts showed CC50 of 124.9 and 123.6 µg/mL, whereas in the case of methanol extract, it was above 250 µg/mL.

4. Conclusions {#sec4-foods-09-00705}
==============

The present work presents interesting scientific data on the potential of *Fibigia clypeata* in the management of Alzheimer's disease, type II diabetes, and skin hyperpigmentation problems. Cytotoxicity studies also supported the action of *F. clypeata* against cancerous cell lines, thereby advocating further investigation geared towards assessing the anti-cancer properties of *F. clypeata*. Higher enzyme inhibition and in vitro antioxidant capabilities were noted for the methanolic extract, showing that the choice of solvent greatly affected the extraction of bioactive compounds from the plant material. Therefore, considering the potential health-implication given by this plant-food for human nutrition, both in vivo and bioavailability studies appear to be strongly required to further support the preliminary data collected in the present study.

The following are available online at <https://www.mdpi.com/2304-8158/9/6/705/s1>, Table S1: Pearson's correlation coefficients considering the different in vitro spectrophotometric and enzymatic assays.
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foods-09-00705-t001_Table 1

###### 

Total bioactive components in the tested extracts. Values are expressed as the mean (*n* = 3) ± standard deviation. GAE: Gallic acid equivalent; RE: Rutin equivalent. Different superscript letters in the same column indicate significant differences (*p* \< 0.05), as determined by Duncan's post-hoc test.

  Extracts        Total Phenolic Content (mg GAE/g)   Total Flavonoid Content (mg RE/g)
  --------------- ----------------------------------- -----------------------------------
  Ethyl acetate   21.04 ± 0.68 ^a^                    10.13 ± 0.39 ^b^
  Methanolic      33.42 ± 3.79 ^b^                    21.58 ± 0.16 ^c^
  Water           24.43 ± 0.21 ^a^                    5.81 ± 0.07 ^a^

foods-09-00705-t002_Table 2

###### 

Tentative identification of phytochemical compounds characterizing the different extracts, as resulted by HPLC-ESI-QTOF-MS analysis.

  Compound   Tentative Identification                                           RT (Min)   Molecular Formula      Molecular Weight   \[M-H\]    Fragments (*m/z*)                                                                Extracts          References
  ---------- ------------------------------------------------------------------ ---------- ---------------------- ------------------ ---------- -------------------------------------------------------------------------------- ----------------- -------------------------------------------------
  **1**      Caffeic acid-*O*-hexoside derivative                               1.725                             388.1247           387.1247   341.1180; 179.0121                                                               EA, MeOH, Water   \[[@B20-foods-09-00705]\]
  **2**      Ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate                        2.120      C~11~H~14~O~4~         210.0051           209.0051   190.9851; 172.9663; 146.9663; 128.9377; 102.9125                                 Water             \[[@B21-foods-09-00705]\]
  **3**      Quinic acid                                                        2.773      C~7~H~12~O~6~          192.0205           191.0205   173.0034; 127.0437; 111.0463                                                     MeOH, Water       \[[@B20-foods-09-00705]\]
  **4**      *p*-Methoxy-2-hydroxy-2-phenylethyl glucosinolate                  4.825      C~16~H~23~NO~11~S~2~   469.0042           468.0042   388.0458; 274.9727; 259.0033; 240.9840; 225.9687; 194.9916; 139.3081; 135.9009   MeOH, Water       \[[@B22-foods-09-00705]\]
  **5**      *p*-Methoxy-2-hydroxy-2-phenylethyl glucosinolate--desulfo         5.018      C~16~H~23~NO~8~S       389.0527           388.0455   274.9727; 259.0033; 240.9840; 225.9687; 194.9916; 139.3081; 135.9009             MeOH, Water       \[[@B22-foods-09-00705]\]
  **6**      Dihydroxybenzoic acid hexoside                                     15.386     C~13~H~16~O~9~         316.0741           315.0741   153.0440; 109.0311                                                               Water             \[[@B20-foods-09-00705]\]
  **7**      Dihydroxybenzoic acid hexoside                                     17.781     C~13~H~16~O~9~         316.0772           315.0772   153.0440; 109.0311                                                               Water             \[[@B20-foods-09-00705]\]
  **8**      *p*-Coumaric acid ethyl ester derivative                           18.460                            314.0613           313.0613   191.0031; 172.9730; 1146.9803; 128.9525                                          Water             \[[@B20-foods-09-00705]\]
  **9**      *p*-Coumaric acid ethyl ester derivative                           19.622                            314.0613           313.0613   191.9672; 172.9696; 146.9676; 128.9426                                           Water             \[[@B20-foods-09-00705]\]
  **10**     2-hydroxy-3-phenylpropanoic acid hexoside                          20.062     C~15~H~20~O~8~         328.1154           327.1154   165.0021; 146.9606; 128.9594; 100.9476                                           EA                \[[@B23-foods-09-00705]\]
  **11**     Rhamnoside of ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate isomer   20.466     C~17~H~24~O~8~         356.0780           355.0780   209.0037; 191.0097; 181.3211; 163.0022; 146.9911                                 Water             \[[@B23-foods-09-00705]\]
  **12**     Rhamnoside of ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate isomer   21.598     C~17~H~24~O~8~         356.0780           355.0780   209.0401; 191.0162; 181.3317; 163.0043; 146.9924                                 Water             \[[@B23-foods-09-00705]\]
  **13**     Benzoic acid                                                       21.641     C~7~H~6~O~2~           122.0369           121.0369   \-                                                                               EA                \[[@B23-foods-09-00705]\]
  **14**     Feruloyl, ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate              22.395     C~17~H~22~O~10~        386.0912           385.0912   209.0082; 190.9877; 146.9696; 129.9443                                           Water             \[[@B23-foods-09-00705]\]
  **15**     Sinapic acid hexoside derivative                                   22.488                            432.2047           431.2047   385.2424; 223.1204                                                               MeOH, Water       \[[@B24-foods-09-00705],[@B25-foods-09-00705]\]
  **16**     *p*-Coumaric acid hexoside                                         22.687     C~15~H~18~O~8~         326.0987           325.0987   162.9889.;144.9626; 119.0003                                                     EA                \[[@B20-foods-09-00705]\]
  **17**     *p*-Coumaric acid ethyl ester derivative                           23.203                            314.0613           313.0613   190.9426; 172.9625; 146.9600; 128.9344; 120.9409                                 Water             \[[@B20-foods-09-00705]\]
  **18**     *p*-coumaroyl acetic acid derivative                               23.407                            388.1763           387.1763   207.0850; 163.0775                                                               MeOH              \[[@B21-foods-09-00705]\]
  **19**     Protocatechuic acid derivative                                     23.613                            432.2013           431.2013   385.1909; 223.1168; 153.0360                                                     EA                \[[@B21-foods-09-00705]\]
  **20**     Rhamnoside of ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate          23.976     C~17~H~24~O~8~         356.0780           355.0780   209.0074; 190.9903                                                               Water             \[[@B23-foods-09-00705]\]
  **21**     (Epi)catechin                                                      24.569     C~15~H~14~O~6~         290.0440           289.0440   245.0665; 205.0202; 125.9405                                                     MeOH              \[[@B20-foods-09-00705]\]
  **22**     Phenylacetic acid                                                  24.773     C~8~H~8~O~2~           136.0057           135.0057   \-                                                                               EA                \[[@B20-foods-09-00705]\]
  **23**     Feruloyl, ethyl 2-hydroxy-3-(hydroxyphenyl)propanoate              24.994     C~17~H~22~O~10~        386.0912           385.0912   223.01146; 209.0082; 190.9877; 146.9696; 129.9443                                Water             \[[@B23-foods-09-00705]\]
  **24**     *O*-sinapoyl-glucose                                               25.870     C~17~H~22~O~10~        386.1268           385.1268   223.0670;                                                                        MeOH, Water       \[[@B25-foods-09-00705]\]
  **25**     Vanilic acid derivative hexoside                                   26.244                            508.2029           507.2029   345.1089; 327.1215; 315.1409; 167.0116                                           EA                \[[@B21-foods-09-00705]\]
  **26**     Ellagic acid                                                       26.397     C~14~H~6~O~8~          302.1221           301.1221   283.1089; 271.1000; 160.9988; 125.9795                                           EA                \[[@B21-foods-09-00705]\]
  **27**     Sinapic acid derivative                                            27.423                            312.1533           311.1533   223.8222; 208.0325                                                               EA                \[[@B24-foods-09-00705],[@B25-foods-09-00705]\]
  **28**     Caffeic acid derivative                                            28.138                            416.2092           415.2092   179.0079; 137.0253                                                               MeOH              \[[@B21-foods-09-00705]\]
  **29**     Quercetin-*O*-hexoside                                             29.159     C~21~H~20~O~12~        464.1014           463.1014   301.0300; 178.9275; 150.9379                                                     MeOH              \[[@B20-foods-09-00705]\]
  **30**     Dimethoxy-trihydroxyflavone                                        30.177     C~17~H~14~O~7~         300.1051           299.1051   269.0865                                                                         EA                \[[@B23-foods-09-00705]\]
  **31**     Ferulic acid                                                       30.672     C~10~H~10~O~4~         194.0153           193.0153   160.9938; 151.0017; 133.9934                                                     MeOH              \[[@B21-foods-09-00705],[@B23-foods-09-00705]\]
  **32**     Kaempferol glucoside                                               30.710     C~21~H~20~O~11~        448.1060           447.1060   285.0817                                                                         MeOH              \[[@B14-foods-09-00705]\]
  **33**     Caffeic acid derivative                                            30.788                            362.1790           361.1790   193.0563; 179.0297; 165.0047; 146.9725; 135.9938; 120.9468                       Water             \[[@B20-foods-09-00705]\]
  **34**     Quercetin derivative                                               30.905                            550.0995           549.0995   505.1463; 301.0477                                                               MeOH              \[[@B20-foods-09-00705]\]
  **35**     Gallic acid derivative                                             31.085                            188.0603           187.0603   169.0445; 125.0163                                                               EA                \[[@B21-foods-09-00705]\]
  **36**     Caffeic acid derivative                                            32.040                            362.1765           361.1765   301.1126; 285.2249; 179.0294; 165.0075; 146.9873; 120.9487                       EA                \[[@B21-foods-09-00705]\]
  **37**     Unidentified                                                       32.203                            306.0734           305.0734   225.0952                                                                         MeOH, Water       
  **38**     Unidentified dimer                                                 33.506                            896.3362           895.3362   447.1766; 403.1865; 343.1615                                                     MeOH, Water       
  **39**     Dihydrocoumaric acid derivative                                    34.565                            246.0071           244.9989   165.0111                                                                         MeOH, Water       \[[@B20-foods-09-00705]\]
  **40**     Trihydroxy-methoxyflavone derivative hexoside                      35.032                            920.2537           919.2537   757.2071; 461.1288; 299.0536; 284.0217                                           Water             \[[@B14-foods-09-00705]\]
  **41**     Unidentified                                                       36.106                            534.1841           533.1841   445.2067; 385.1792; 343.1590; 163.0220                                           Water             
  **42**     Tetrahydroxy-dimethoxyflavone                                      36.744     C~17~H~14~O~8~         346.0740           345.0740   330.0496; 315.0293                                                               Water             \[[@B14-foods-09-00705]\]
  **43**     Caffeyl alcohol O-glucopyranoside                                  37.102     C~15~H~20~O~8~         328.2227           327.2227   229.1231; 165.0727; 121.0198                                                     EA, MeOH, Water   \[[@B23-foods-09-00705]\]
  **44**     Sesquiterpene-derivative                                           38.691                            330.2386           329.2386   289.1532; 229.1252; 211.1104; 129.0162                                           MeOH, Water       
  **45**     Trihydroxy-methoxyflavone                                          39.570     C~16~H~12~O~6~         300.0572           299.0572   284.0313                                                                         EA                \[[@B14-foods-09-00705]\]
  **46**     Sesquiterpene-derivative                                           43.427                            308.1944           307.1944   289.1829; 235.1171; 209.0913; 185.0827; 120.9816                                 MeOH, Water       
  **47**     Ferulic acid derivative                                            44.078                            294.1770           293.1770   236.0898; 221.1337; 193.1262                                                     EA, MeOH, Water   \[[@B21-foods-09-00705]\]
  **48**     Phenylacetic acid derivative                                       45.795                            306.1786           305.1786   249.1359; 135.0091; 125.0171;                                                    EA                \[[@B20-foods-09-00705]\]
  **49**     Sinapic acid derivative                                            45.927                            312.2265           311.2265   223.1479; 208.4343                                                               MeOH, Water       \[[@B24-foods-09-00705],[@B25-foods-09-00705]\]
  **50**     Sinapine                                                           46.770     C~16~H~24~NO~5~        310.2099           309.2099   291.2122; 251.1664; 223.1588; 208.6589                                           EA                \[[@B25-foods-09-00705]\]
  **51**     Sesquiterpene-derivative                                           47.632                            310.2099           309.2099   291.1943; 225.1275; 197.0855; 110.9822                                           EA                

foods-09-00705-t003_Table 3

###### 

Enzyme inhibitory activities of the tested extracts. Values are expressed as mean (*n* = 3) ± standard deviation. GALAE: Galantamine equivalent; KAE: Kojic acid equivalent; ACAE: Acarbose equivalent; na = not active. Different superscript letters in the same column indicate significant differences (*p* \< 0.05), as determined by Duncan's post-hoc test.

  Extracts        AChE Inhibition (mg GALAE/g)   BChE Inhibition (mg GALAE/g)   Tyrosinase Inhibition (mg KAE/g)   Amylase Inhibition (mmol ACAE/g)   Glucosidase Inhibition (mmol ACAE/g)
  --------------- ------------------------------ ------------------------------ ---------------------------------- ---------------------------------- --------------------------------------
  Ethyl acetate   3.49 ± 0.16 ^b^                3.54 ± 0.43 ^b^                115.07 ± 3.14 ^b^                  0.73 ± 0.04 ^c^                    22.32 ± 1.15 ^b^
  Methanolic      4.87 ± 0.57 ^c^                3.52 ± 0.11 ^b^                126.80 ± 0.39 ^c^                  0.55 ± 0.03 ^b^                    24.68 ± 0.03 ^c^
  Water           na ^a^                         na ^a^                         43.11 ± 5.14 ^a^                   0.11 ± 0.01 ^a^                    1.06 ± 0.20 ^a^

foods-09-00705-t004_Table 4

###### 

In vitro antioxidant properties of the tested extracts. Values are expressed as the mean (*n* = 3) ± standard deviation. TE: Trolox equivalents; EDTAE: EDTA equivalents. Different superscript letters in the same column indicate significant differences (*p* \< 0.05), as determined by Duncan's post-hoc test.

  Extracts        DPPH (mg TE/g)     ABTS (mg TE/g)      CUPRAC (mg TE/g)    FRAP (mg TE/g)      Phosphomolybdenum (mmol TE/g)   Chelating Ability (mg EDTAE/g)
  --------------- ------------------ ------------------- ------------------- ------------------- ------------------------------- --------------------------------
  Ethyl acetate   22.38 ± 0.37 ^a^   15.61 ± 0.58 ^a^    78.41 ± 4.04 ^a^    28.53 ± 1.47 ^a^    1.91 ± 0.05 ^b^                 25.21 ± 1.20 ^b^
  Methanolic      96.52 ± 0.10 ^c^   109.10 ± 2.57 ^c^   154.02 ± 4.58 ^c^   104.85 ± 0.57 ^c^   1.79 ± 0.15 ^b^                 21.18 ± 1.72 ^a^
  Water           40.21 ± 1.24 ^b^   90.98 ± 1.00 ^b^    108.02 ± 1.01 ^b^   75.18 ± 0.77 ^b^    1.25 ± 0.11 ^a^                 31.64 ± 0.87 ^c^

foods-09-00705-t005_Table 5

###### 

Cytotoxicity potential of the tested extracts. na = not applicable.

           CC~50~ (µg/mL)                    
  -------- ---------------- ---------------- ----------------
  VERO     \>500            na               na
  FaDu     231.6 ± 13.97    363.13 ± 19.56   \>500
  SCC-25   554.57 ± 62.34   408.43 ± 48.52   412.43 ± 51.61

foods-09-00705-t006_Table 6

###### 

Classification of plant extracts cytotoxicity according to National Cancer Institute.

  CC~50~ Value         \<20 μg/mL   21--200 μg/mL   201--500 μg/mL   \>500 μg/mL
  -------------------- ------------ --------------- ---------------- -------------
  Cytotoxic activity   high         moderate        weak             no activity
